Fig. 5From: 99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry studyAverage time-activity curves for the organs with the highest tracer uptake, as a percentage of the IA for the different organs, with standard deviations and exponential fitsBack to article page